Roche drops $1.85B for Gen­Mark's test­ing tech as pan­dem­ic, an­tibi­ot­ic re­sis­tance threats loom

Roche has on­ly played a mi­nor role in the hunt for Covid-19 drugs and vac­cines. In­stead, the Swiss gi­ant made their in­flu­ence in a field …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.